Analysis of angiotensin II-Induced rat urinary bladder contractions in the presence of angiotensin II receptors blockers

Arch Physiol Biochem. 2021 Feb;127(1):1-5. doi: 10.1080/13813455.2018.1555669. Epub 2019 Feb 10.

Abstract

Objective: An application of a specific analysis on recordings obtained from urinary bladder (UB) preparations influenced with Angiotensin II (AngII) and AngII receptor (ATR) blockers was performed.

Methods: UB preparations were divided as follows: group 1 stimulated with AngII only; group 2:PD123319 (ATR type-2 blocker)+AngII; group 3:Losartan (ATR type-1 blocker)+AngII. The averaged time and force parameters of the contractions were processed by a spline interpolation and graphic images of the different patterns of the contractile activity were obtained.

Results: The speed of AngII-induced UB contraction, when PD123319 was administered, was significantly higher than those, registered by the application of AngII alone and Losartan + AngII. The presence of Losartan markedly delayed the speed of the overall AngII-induced contraction.

Conclusion: The study indicates the contribution of both ATR subtypes for the development of AngII-induced UB contraction. Our results showed that probably ATR mediate a reciprocal dynamic response to AngII in the bladder.

Keywords: Angiotensin II receptors; smooth muscle contraction; urinary bladder.

MeSH terms

  • Angiotensin II / metabolism*
  • Angiotensin II Type 1 Receptor Blockers / pharmacology*
  • Angiotensin Receptor Antagonists / metabolism
  • Animals
  • Homeostasis
  • Imidazoles / pharmacology
  • Losartan / pharmacology
  • Male
  • Pyridines / pharmacology
  • Rats
  • Rats, Wistar
  • Stress, Mechanical
  • Urinary Bladder / drug effects*

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Angiotensin Receptor Antagonists
  • Imidazoles
  • Pyridines
  • Angiotensin II
  • PD 123319
  • Losartan